| Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features N Zmora, G Zilberman-Schapira, J Suez, U Mor, M Dori-Bachash, ... Cell 174 (6), 1388-1405. e21, 2018 | 1242 | 2018 |
| Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT J Suez, N Zmora, G Zilberman-Schapira, U Mor, M Dori-Bachash, ... Cell 174 (6), 1406-1423. e16, 2018 | 934 | 2018 |
| Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex Y Gore, D Starlets, N Maharshak, S Becker-Herman, U Kaneyuki, L Leng, ... Journal of Biological Chemistry 283 (5), 2784-2792, 2008 | 309 | 2008 |
| Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis O Kimhi, D Caspi, NM Bornstein, N Maharshak, A Gur, Y Arbel, ... Seminars in arthritis and rheumatism 36 (4), 203-209, 2007 | 284 | 2007 |
| NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth L Chen, JE Wilson, MJ Koenigsknecht, WC Chou, SA Montgomery, ... Nature immunology 18 (5), 541-551, 2017 | 237 | 2017 |
| High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals Y Ringel, N Maharshak, T Ringel-Kulka, EA Wolber, RB Sartor, IM Carroll Gut microbes 6 (3), 173-181, 2015 | 189 | 2015 |
| Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation S Federici, S Kredo-Russo, R Valdés-Mas, D Kviatcovsky, E Weinstock, ... Cell 185 (16), 2879-2898. e24, 2022 | 180 | 2022 |
| Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome Y Ringel, N Maharshak American Journal of Physiology-Gastrointestinal and Liver Physiology 305 (8 …, 2013 | 157 | 2013 |
| A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial BD Huttner, V De Lastours, M Wassenberg, N Maharshak, A Mauris, ... Clinical microbiology and infection 25 (7), 830-838, 2019 | 151 | 2019 |
| Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation N Maharshak, CD Packey, M Ellermann, S Manick, JP Siddle, EY Huh, ... Gut microbes 4 (4), 316-324, 2013 | 147 | 2013 |
| CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system I Dotan, L Werner, S Vigodman, S Weiss, E Brazowski, N Maharshak, ... Inflammatory bowel diseases 16 (4), 583-592, 2010 | 143 | 2010 |
| Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance JC Onyiah, SZ Sheikh, N Maharshak, EC Steinbach, SM Russo, ... Gastroenterology 144 (4), 789-798, 2013 | 125 | 2013 |
| The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial H Yanai, A Levine, A Hirsch, RS Boneh, U Kopylov, HB Eran, NA Cohen, ... The Lancet Gastroenterology & Hepatology 7 (1), 49-59, 2022 | 116 | 2022 |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls J Shapiro, NA Cohen, V Shalev, A Uzan, O Koren, N Maharshak The Journal of dermatology 46 (7), 595-603, 2019 | 115 | 2019 |
| Efficacy and safety of vedolizumab for induction of remission in inflammatory bowel disease—the Israeli real-world experience U Kopylov, Y Ron, I Avni-Biron, B Koslowsky, M Waterman, S Daher, ... Inflammatory bowel diseases 23 (3), 404-408, 2017 | 100 | 2017 |
| Fecal and mucosa-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome N Maharshak, Y Ringel, D Katibian, A Lundqvist, RB Sartor, IM Carroll, ... Digestive diseases and sciences 63, 1890-1899, 2018 | 98 | 2018 |
| Enteric bacterial proteases in inflammatory bowel disease-pathophysiology and clinical implications IM Carroll, N Maharshak World Journal of Gastroenterology: WJG 19 (43), 7531, 2013 | 96 | 2013 |
| Pouch inflammation is associated with a decrease in specific bacterial taxa L Reshef, A Kovacs, A Ofer, L Yahav, N Maharshak, N Keren, FM Konikoff, ... Gastroenterology 149 (3), 718-727, 2015 | 92 | 2015 |
| Cutaneous manifestations of internal malignancies S Brenner, E Tamir, N Maharshak, J Shapira Clinics in dermatology 19 (3), 290-297, 2001 | 90 | 2001 |
| A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS K Hod, AD Sperber, Y Ron, M Boaz, R Dickman, S Berliner, Z Halpern, ... Neurogastroenterology & Motility 29 (7), e13037, 2017 | 87 | 2017 |
